Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,618 | -90,398 | -51,166 | -21,379 | -59,802 |
| Depreciation Amortization | 7,021 | 4,604 | 2,696 | 1,166 | 4,284 |
| Accounts payable and accrued liabilities | -1,982 | -544 | 4,777 | 437 | 3,177 |
| Other Working Capital | 7,736 | 4,866 | 6,039 | 146 | 2,166 |
| Other Operating Activity | 26,866 | 15,939 | 2,722 | 1,971 | 5,541 |
| Operating Cash Flow | $-105,977 | $-65,533 | $-34,932 | $-17,659 | $-44,634 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -285,855 | -255,591 | -112,783 | -2,248 | -120,998 |
| PPE Investments | -4,955 | -3,032 | -1,054 | -459 | -2,149 |
| Other Investing Activity | -1,541 | -168 | -1,239 | -1,358 | -293 |
| Investing Cash Flow | $-292,351 | $-258,791 | $-115,076 | $-4,065 | $-123,440 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 467,573 | 466,686 | 178,035 | 175,440 | 189,317 |
| Dividend Paid | N/A | N/A | N/A | N/A | -4,346 |
| Financing Cash Flow | $467,573 | $466,686 | $178,035 | $175,440 | $184,971 |
| Beginning Cash Position | 24,324 | 24,324 | 24,324 | 24,324 | 7,427 |
| End Cash Position | 93,569 | 166,686 | 52,351 | 178,040 | 24,324 |
| Net Cash Flow | $69,245 | $142,362 | $28,027 | $153,716 | $16,897 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,977 | -65,533 | -34,932 | -17,659 | -44,634 |
| Capital Expenditure | -4,955 | -3,032 | -1,054 | -459 | -2,149 |
| Free Cash Flow | -110,932 | -68,565 | -35,986 | -18,118 | -46,783 |